{
    "nct_id": "NCT06625034",
    "official_title": "Randomized Phase III Trial of Rapid-Plan Knowledge-Based Planning vs. Human-Driven Planning for Prostate Cancer Radiotherapy",
    "inclusion_criteria": "* Patients must be at least 18 years old\n* Histologically confirmed prostate cancer\n* Clinical or pathologic stages T1c-T3b, Nx or N0-1, M0-1 (American Joint Committee on Cancer [AJCC] criteria 8th edition [Ed])\n* Planned definitive dose radiotherapy to the prostate or prostate bed\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2 assessed within 90 days of enrollment\n* Patients must sign Institutional Review Board (IRB) approved study specific informed consent\n* Patients must complete all required pre-entry tests within the specified time frames\n* Patients must be able to start treatment (radiation) within 180 days of study registration\n* In case of confusion about the eligibility or ineligibility of an individual patient, the principal investigator (PI) can be used as the arbiter and a note to file will be added to the subject's regulatory binder to document outcome\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous pelvic radiation > 5 Gy\n* Planned delivery of radiotherapy to pelvic lymph nodes\n* Planned delivery of brachytherapy of the prostate\n* Active rectal diverticulitis, Crohn's disease affecting the rectum, or ulcerative colitis (non-active diverticulitis and Crohn's disease not affecting the rectum are allowed)\n* Prior hip replacement or penile implant\n* Major medical, addictive, or psychiatric illness which in the investigator's opinion, will prevent the consent process, completion of the treatment and/or interfere with follow-up. (consent by legal authorized representative is not permitted for this study)\n* Indwelling or intermittent urinary catheter use",
    "miscellaneous_criteria": ""
}